Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Wound catheter ropivacaine infusion to reduce postoperative opioid use after major abdominal surgery in infants
NL-OMON47384Phase 3Active, not recruiting
- Sponsor
- Erasmus MC
- Start
- Dec 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ropivacaine in postoperative pain (2 arms), sponsored by Erasmus MC. Primary endpoint: Cumulative morphine use over 48 hours. Started Dec 2017; status: active, not recruiting.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NL-OMON47384.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON47384.